LTC Natalie Collins, Director of EIDB at WRAIR, and Dr. Gordon Joyce are presenting at the 31st Conference on Retroviruses and Opportunistic Infections (CROI).
LTC Natalie Collins
- Title: (02827) First-in-Human Phase I Trial of an Adjuvanted SARS-CoV-2 Spike Ferritin Nanoparticle Vaccine
- Date/Time: March 5, 2:30 - 4:30 PM MST
- Session: Treatment and Prevention of SARS-CoV-2 Infection - Poster Session-G6
Gordon Joyce
- Title: (01331) Sarbecovirus Ferritin Nanoparticle Vaccines as Protein or mRNA-LNP Elicit Broad Immunogenicity"
- Date/Time: March 4, 2:30 - 4:30 PM MST
- Session: COVID-19 Vaccines -Poster Session-C3